154 related articles for article (PubMed ID: 33841635)
41. Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles.
Zhou Y; Gu H; Xu Y; Li F; Kuang S; Wang Z; Zhou X; Ma H; Li P; Zheng Y; Ran H; Jian J; Zhao Y; Song W; Wang Q; Wang D
Theranostics; 2015; 5(4):399-417. PubMed ID: 25699099
[TBL] [Abstract][Full Text] [Related]
42. miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
Jia L; Xi Q; Wang H; Zhang Z; Liu H; Cheng Y; Guo X; Zhang J; Zhang Q; Zhang L; Xue Z; Li Y; Da Y; Zhao P; Zhang R
Biochem Biophys Res Commun; 2017 Jun; 488(2):425-431. PubMed ID: 28511795
[TBL] [Abstract][Full Text] [Related]
43. Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy.
Guo LM; Ding GF; Xu WC; Ge H; Jiang Y; Lu YF
Oxid Med Cell Longev; 2022; 2022():5938688. PubMed ID: 35295718
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer.
Liang Y; Wang W; Zhu X; Yu M; Zhou C
Sci Rep; 2022 Jun; 12(1):9619. PubMed ID: 35688951
[TBL] [Abstract][Full Text] [Related]
45. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
[TBL] [Abstract][Full Text] [Related]
46. A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study.
Shadbad MA; Ghorbaninezhad F; Hassanian H; Ahangar NK; Hosseinkhani N; Derakhshani A; Shekari N; Brunetti O; Silvestris N; Baradaran B
Front Med (Lausanne); 2022; 9():1027758. PubMed ID: 36388933
[TBL] [Abstract][Full Text] [Related]
47. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
[TBL] [Abstract][Full Text] [Related]
48. Evodiamine suppresses non-small cell lung cancer by elevating CD8
Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
[TBL] [Abstract][Full Text] [Related]
49. A novel UTMD system facilitating nucleic acid delivery into MDA-MB-231 cells.
Zhang H; Li Y; Rao F; Liufu C; Wang Y; Chen Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990029
[TBL] [Abstract][Full Text] [Related]
50. Ultrasound-Induced Microbubble Cavitation Combined with miR-34a-Loaded Nanoparticles for the Treatment of Castration-Resistant Prostate Cancer.
Wang Z; Chen C; Tao Y; Zou P; Gao F; Jia C; Liu L; Li G; Zhang G; Duan Y; Shi Q
J Biomed Nanotechnol; 2021 Jan; 17(1):78-89. PubMed ID: 33653498
[TBL] [Abstract][Full Text] [Related]
51. Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.
Tada A; Minami T; Kitai H; Higashiguchi Y; Tokuda M; Higashiyama T; Negi Y; Horio D; Nakajima Y; Otsuki T; Mikami K; Takahashi R; Nakamura A; Kitajima K; Ohmuraya M; Kuribayashi K; Kijima T
Lung Cancer; 2023 Jun; 180():107219. PubMed ID: 37146474
[TBL] [Abstract][Full Text] [Related]
52.
Sun S; Tang Q; Wang Y; Zhang L; Chen J; Xu M; Sun L; Cui L; Liang X
ACS Appl Mater Interfaces; 2022 Jun; ():. PubMed ID: 35657950
[TBL] [Abstract][Full Text] [Related]
53. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
[TBL] [Abstract][Full Text] [Related]
54. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.
Jiang K; Zou H
Bioengineered; 2022 Jan; 13(1):917-929. PubMed ID: 34968160
[TBL] [Abstract][Full Text] [Related]
55. Inducing Tumor Cell Apoptosis: Mediated Survivin miRNA by Ultrasound and Cationic Lipid Contrast Agent.
Yang F; Chun LF; Chen ZY
Curr Mol Med; 2021; 21(9):795-805. PubMed ID: 32912126
[TBL] [Abstract][Full Text] [Related]
56. MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint.
Tao Z; Xu S; Ruan H; Wang T; Song W; Qian L; Chen K
Cell Physiol Biochem; 2018; 48(2):801-814. PubMed ID: 30032144
[TBL] [Abstract][Full Text] [Related]
57. The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer.
Hosseini M; Baghaei K; Hajivalili M; Zali MR; Ebtekar M; Amani D
Life Sci; 2022 Feb; 290():120234. PubMed ID: 34953890
[TBL] [Abstract][Full Text] [Related]
58. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy.
Huang Y; Wang L; Chen Y; Han H; Li Q
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443415
[TBL] [Abstract][Full Text] [Related]
59. Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma.
Wei T; Li M; Zhu Z; Xiong H; Shen H; Zhang H; Du Q; Li Q
J Cancer Res Clin Oncol; 2021 Mar; 147(3):691-701. PubMed ID: 33389078
[TBL] [Abstract][Full Text] [Related]
60. Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer.
Sun L; Zhang J; Xu M; Zhang L; Tang Q; Chen J; Gong M; Sun S; Ge H; Wang S; Liang X; Cui L
ACS Appl Mater Interfaces; 2022 Jan; 14(1):452-463. PubMed ID: 34961307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
